Navigation Links
LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology
Date:2/20/2013

PHILADELPHIA, Feb. 20, 2013 /PRNewswire/ -- LaserLock Technologies, Inc. (OTCBB: LLTI), a global leader in providing state-of-the-art authentication solutions to governments, pharmaceuticals, high-end retailers, and casinos announced it has filed a provisional patent application for a Characteristic Verification System (CVS) enabling smart phones to simultaneously identify counterfeit products and protect against identity fraud. The CVS is a groundbreaking technology that sets a new standard in brand protection by combining LaserLock's proven product authentication expertise with its recently acquired VerifyMe™ human authentication technology.  

Acquired by LaserLock Technologies in December 2012, VerifyMe™ is a biometric verification system that uses a smartphone platform and a variety of methods to quickly and accurately prove the identity of any human being. It can also uniquely serialize individual products allowing complete verification of provenance, pedigree and movement.  The new solution benefits from the near ubiquitous penetration of smart phones with integrated cameras and artificial light sources to create advanced inspection tools that can be made available at no additional cost.

"LaserLock's new CVS provisional patent application is uniquely well-suited to take advantage of the increasing demand for more effective, more economical and more efficient authentication technology along supply chains," said Neil Alpert , President of LaserLock Technologies. "This provisional patent application is a potential game-changer for our company and our industry."

The Characteristic Verification System utilizes technologies present in virtually all smartphones to capture both overt and covert anti-counterfeiting measures on any given product, as well as verify the identity of the person performing that action. Its applications range from protecting the most complex and sensitive supply chains to protecting the integrity of high-value retail goods.

"As more industries demand both human and product authentication simultaneously, LaserLock is positioned to assume a leadership role in this arena," said Michael Sonnenreich , Chairman of LaserLock Technologies' Board of Directors. "Just last week, the Institute of Medicine recommended that the United States Congress authorize and fund a mandatory track-and-trace program in the pharmaceutical industry that our technology is already designed to achieve."

Additionally, LaserLock will be releasing VerifyMe™ applications for Android, BlackBerry, iOS and Windows mobile devices including phones and tablets.

ABOUT LASERLOCK TECHNOLOGIES, INC.

LaserLock Technologies, Inc. based in Bala Cynwyd, PA is publicly traded on the OTC Market under the ticker symbol "LLTI". The Company markets security technology to protect pharmaceuticals, high-end retail goods, the casino industry, documents and branded products from counterfeiting. To learn more, visit us at www.laserlocktech.com or follow us on Twitter @LaserLockTech.

MEDIA INQUIRIES
Sarah Jane Scruggs
Sage Communications (for LaserLock Technologies)
703-207-0435
sarahs@aboutsage.com

INVESTOR RELATIONS
LaserLock Technologies
IR@laserlocktech.com

 


'/>"/>
SOURCE LaserLock Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
2. New modeling approach transforms imaging technologies
3. Life Technologies ayudar√° a identificar 20.000 restos humanos encontrados en fosas comunes en Libia
4. New supercomputer coming to EMSL this summer, supplied by Atipa Technologies
5. UT Dallas researchers awarded $4.3 million to create next-generation technologies
6. ASU partners with Life Technologies on US DHHS funded project to rapidly assess radiation dose
7. Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center
8. NREL researchers use imaging technologies to solve puzzle of plant architecture
9. New energy technologies promise brighter future
10. Cross Match Technologies Undoubtedly Offers the Highest Value to Customers in the North American Biometrics Market, Says Frost & Sullivan
11. Life Technologies to supply new Covaris DNA fragmenting products for Ion Torrent Semiconductor Sequencers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/8/2017)... Feb. 8, 2017 About Voice Recognition Biometrics ... match it against a stored voiceprint template. Acoustic ... cadence, and tone are compared to distinguish between ... installation, as most PCs already have a microphone ... Voice recognition biometrics are most likely to be ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... Israel , March 27, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... party insurance coverage option for U.S. consumers who want ... DarioHealth has signed strategic alliance agreements with ... verify insurance coverage benefits, and if approved, will supply ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... (hESC) Research - Global Strategic Business Report" report to their ... This ... Research in US$ Million. Annual estimates and forecasts are provided for ... from primary and secondary research. The report profiles ...
(Date:3/24/2017)... -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with ... today announced participation at the following conferences: ... Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at the ... York, NY . Agenus will participate in three ... Robert B. Stein , M.D., Ph.D., President, R&D ...
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
Breaking Biology Technology: